Literature DB >> 24019132

Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.

Vani J A Konda1, Lusik Cherkezyan, Hariharan Subramanian, Kirsten Wroblewski, Dhwanil Damania, Valentin Becker, Mariano Haba Ruiz Gonzalez, Ann Koons, Michael Goldberg, Mark K Ferguson, Irving Waxman, Hermant K Roy, Vadim Backman.   

Abstract

BACKGROUND AND STUDY AIMS: Esophageal adenocarcinoma (EAC) has a dismal prognosis unless treated early or prevented at the precursor stage of Barrett's esophagus-associated dysplasia. However, some patients with cancer or dysplastic Barrett's esophagus (DBE) may not be captured by current screening and surveillance programs. Additional screening techniques are needed to determine who would benefit from endoscopic screening or surveillance. Partial wave spectroscopy (PWS) microscopy (also known as nanocytology) measures the disorder strength (Ld ), a statistic that characterizes the spatial distribution of the intracellular mass at the nanoscale level and thus provides insights into the cell nanoscale architecture beyond that which is revealed by conventional microscopy. The aim of the present study was to compare the disorder strength measured by PWS in normal squamous epithelium in the proximal esophagus to determine whether nanoscale architectural differences are detectable in the field area of EAC and Barrett's esophagus.
METHODS: During endoscopy, proximal esophageal squamous cells were obtained by brushings and were fixed in alcohol and stained with standard hematoxylin and Cyto-Stain. The disorder strength of these sampled squamous cells was determined by PWS.
RESULTS: A total of 75 patient samples were analyzed, 15 of which were pathologically confirmed as EAC, 13 were DBE, and 15 were non-dysplastic Barrett's esophagus; 32 of the patients, most of whom had reflux symptoms, acted as controls. The mean disorder strength per patient in cytologically normal squamous cells in the proximal esophagus of patients with EAC was 1.79-times higher than that of controls (P<0.01). Patients with DBE also had a disorder strength 1.63-times higher than controls (P<0.01).
CONCLUSION: Intracellular nanoarchitectural changes were found in the proximal squamous epithelium in patients harboring distal EAC and DBE using PWS. Advances in this technology and the biological phenomenon of the field effect of carcinogenesis revealed in this study may lead to a useful tool in non-invasive screening practices in DBE and EAC. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24019132      PMCID: PMC4195538          DOI: 10.1055/s-0033-1344617

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  22 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

2.  Refractive index of concentrated protein solutions.

Authors:  R BARER; S TKACZYK
Journal:  Nature       Date:  1954-05-01       Impact factor: 49.962

3.  Colon cancer screening: the good, the bad, and the ugly.

Authors:  Hemant K Roy; Vadim Backman; Michael J Goldberg
Journal:  Arch Intern Med       Date:  2006-11-13

4.  In situ detection of nuclear atypia in Barrett's esophagus by using angle-resolved low-coherence interferometry.

Authors:  John W Pyhtila; Kevin J Chalut; Jeffrey D Boyer; Justin Keener; Thomas D'Amico; Marcia Gottfried; Frank Gress; Adam Wax
Journal:  Gastrointest Endosc       Date:  2007-03       Impact factor: 9.427

Review 5.  Are screening and surveillance for Barrett's oesophagus really worthwhile?

Authors:  P Sharma; E I Sidorenko
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

6.  The influence of chromosome density variations on the increase in nuclear disorder strength in carcinogenesis.

Authors:  Jun Soo Kim; Prabhakar Pradhan; Vadim Backman; Igal Szleifer
Journal:  Phys Biol       Date:  2011-02-07       Impact factor: 2.583

7.  Metabolic profiling detects field effects in nondysplastic tissue from esophageal cancer patients.

Authors:  Danny Yakoub; Hector C Keun; Robert Goldin; George B Hanna
Journal:  Cancer Res       Date:  2010-09-30       Impact factor: 12.701

8.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

9.  Prevalence of Barrett's esophagus in asymptomatic individuals.

Authors:  Lauren B Gerson; Katerina Shetler; George Triadafilopoulos
Journal:  Gastroenterology       Date:  2002-08       Impact factor: 22.682

10.  Smoking-induced gene expression changes in the bronchial airway are reflected in nasal and buccal epithelium.

Authors:  Sriram Sridhar; Frank Schembri; Julie Zeskind; Vishal Shah; Adam M Gustafson; Katrina Steiling; Gang Liu; Yves-Martine Dumas; Xiaohui Zhang; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  BMC Genomics       Date:  2008-05-30       Impact factor: 3.969

View more
  17 in total

Review 1.  Molecular markers and imaging tools to identify malignant potential in Barrett's esophagus.

Authors:  Michael Bennett; Hiroshi Mashimo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

Review 2.  Review of interferometric spectroscopy of scattered light for the quantification of subdiffractional structure of biomaterials.

Authors:  Lusik Cherkezyan; Di Zhang; Hariharan Subramanian; Ilker Capoglu; Allen Taflove; Vadim Backman
Journal:  J Biomed Opt       Date:  2017-03-01       Impact factor: 3.170

3.  Nanoscale refractive index fluctuations detected via sparse spectral microscopy.

Authors:  John E Chandler; Lusik Cherkezyan; Hariharan Subramanian; Vadim Backman
Journal:  Biomed Opt Express       Date:  2016-02-19       Impact factor: 3.732

4.  Optical pre-screening for laryngeal cancer using reflectance spectroscopy of the buccal mucosa.

Authors:  Oisín Bugter; Jose A Hardillo; Robert J Baatenburg de Jong; Arjen Amelink; Dominic J Robinson
Journal:  Biomed Opt Express       Date:  2018-09-06       Impact factor: 3.732

5.  Harnessing novel modalities: field carcinogenesis detection for personalizing prostate cancer management.

Authors:  Navneet Momi; Vadim Backman; Charles B Brendler; Hemant K Roy
Journal:  Future Oncol       Date:  2015-09-16       Impact factor: 3.404

6.  Aberrant p53 Immunostaining in Barrett's Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses.

Authors:  Patrick Snyder; Kerry Dunbar; Daisha J Cipher; Rhonda F Souza; Stuart Jon Spechler; Vani J A Konda
Journal:  Dig Dis Sci       Date:  2019-03-26       Impact factor: 3.199

7.  Procedures for risk-stratification of lung cancer using buccal nanocytology.

Authors:  H Subramanian; P Viswanathan; L Cherkezyan; R Iyengar; S Rozhok; M Verleye; J Derbas; J Czarnecki; H K Roy; V Backman
Journal:  Biomed Opt Express       Date:  2016-08-31       Impact factor: 3.732

Review 8.  Point-of-care and point-of-procedure optical imaging technologies for primary care and global health.

Authors:  Stephen A Boppart; Rebecca Richards-Kortum
Journal:  Sci Transl Med       Date:  2014-09-10       Impact factor: 17.956

9.  Macrogenomic engineering via modulation of the scaling of chromatin packing density.

Authors:  Luay M Almassalha; Greta M Bauer; Wenli Wu; Lusik Cherkezyan; Di Zhang; Alexis Kendra; Scott Gladstein; John E Chandler; David VanDerway; Brandon-Luke L Seagle; Andrey Ugolkov; Daniel D Billadeau; Thomas V O'Halloran; Andrew P Mazar; Hemant K Roy; Igal Szleifer; Shohreh Shahabi; Vadim Backman
Journal:  Nat Biomed Eng       Date:  2017-11-06       Impact factor: 25.671

10.  Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study.

Authors:  Hemant K Roy; Charles B Brendler; Hariharan Subramanian; Di Zhang; Charles Maneval; John Chandler; Leah Bowen; Karen L Kaul; Brian T Helfand; Chi-Hsiung Wang; Margo Quinn; Jacqueline Petkewicz; Michael Paterakos; Vadim Backman
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.